Cowan Elvia

SVP, Finance & CAOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$146K
Net Open-Market Flow
-$146K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2026Sell(S)3K$58.59$146K31K
Mar 11, 2026Option exercise(M)3K$25.92$65K33K
Mar 9, 2026Tax withholding(F)495$59.32$29K31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2026Option exercise(M)3K$096K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001960048-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: